Sonnel Patrick, MD
Allergy & Immunology · Waterbury, CTNPI 1184698565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novartis at 24.3% of the total.
Across 109 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$548
- GSK$286
- Genentech USA, Inc.$237
- Sanofi$175
- Regeneron Healthcare Solutions, Inc.$133
- AbbVie$131
- plus $745 from 17 others
What the payments were for
- Food & beverage$2,22899%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 25 | $548 |
| GSK | 14 | $286 |
| Genentech USA, Inc. | 10 | $237 |
| Sanofi | 8 | $175 |
| Regeneron Healthcare Solutions, Inc. | 6 | $133 |
| AbbVie | 6 | $131 |
| Optinose US, Inc. | 6 | $119 |
| CSL Behring | 3 | $77 |
| Boehringer Ingelheim | 4 | $76 |
| Eyevance Pharmaceuticals LLC | 5 | $73 |
| AstraZeneca | 4 | $70 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| Seqirus USA Inc | 2 | $47 |
| Covis Pharma GmbH | 2 | $38 |
| Amgen | 2 | $33 |
| Kaleo, Inc. | 2 | $29 |
| Biocryst US Sales Co., LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| USWM, LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
How this compares
$2,256 in reported general payments places this provider in the 55th percentile of 54 allergy & immunology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 18 | $9,616 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $9,120 |
| Arnuity ElliptaFluticasone Furoate | 29 | $7,359 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,243 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $5,856 |
| Qvar RedihalerBeclomethasone Dipropionate | 17 | $4,774 |
| AlvescoCiclesonide | 17 | $4,410 |
| Levocetirizine Dihydrochloride | 414 | $3,596 |
| Azelastine Hcl | 98 | $2,515 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $2,368 |
| Fluticasone Propionate | 130 | $1,612 |
| Wixela InhubFluticasone Propion/Salmeterol | 30 | $1,591 |
| Epinephrine | 16 | $1,330 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,094 |
| Hydroxyzine Hcl | 62 | $1,014 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta, Trelegy Ellipta | $286 | $23,21758 claims |
| AstraZenecaSymbicort | $70 | $9,12028 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $15 | $4,77417 claims |
| Covis Pharma GmbHAlvesco | $38 | $4,41017 claims |
| Hikma Pharmaceuticals USAEpinephrine | $14 | $1,33016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 54 allergy & immunology providers in Connecticut.
Other allergy & immunology in Waterbury
- Melvyn RanishWaterbury$1K
- David DreyfusWaterbury$1
- Gavin SchwarzWest Hartford$262K
- Christina PriceNew Haven$96K
- Florence HsuNorth Haven$84K
- Jason LeeWest Hartford$30K
- Birur ChandraEast Haven$15K
- Michael KingTrumbull$14K
- Prasad SrinivasanGlastonbury$14K
- Anita Kohli-PamnaniOrange$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.